NAV

UDP-alpha-D-glucuronic acid

Identification

Generic Name
UDP-alpha-D-glucuronic acid
DrugBank Accession Number
DB03041
Background

A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. [PubChem]

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 580.2853
Monoisotopic: 580.034284934
Chemical Formula
C15H22N2O18P2
Synonyms
  • UDP-alpha-D-glucuronate
  • UDP-D-glucuronate
  • UDP-glucuronate
  • UDP-Glucuronic Acid
  • UDPglucuronate
  • uridine diphosphate glucuronic acid
  • Uridine-5'-diphosphate-glucuronic acid
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UUDP-glucose 4-epimerase
substrate
Humans
UGalactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3Not AvailableHumans
UUDP-glucose 6-dehydrogenaseNot AvailableStreptococcus pyogenes
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as pyrimidine nucleotide sugars. These are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group.
Kingdom
Organic compounds
Super Class
Nucleosides, nucleotides, and analogues
Class
Pyrimidine nucleotides
Sub Class
Pyrimidine nucleotide sugars
Direct Parent
Pyrimidine nucleotide sugars
Alternative Parents
Pyrimidine ribonucleoside diphosphates / Pentose phosphates / Glucuronic acid derivatives / Glycosylamines / Monosaccharide phosphates / Organic pyrophosphates / Beta hydroxy acids and derivatives / Monoalkyl phosphates / Pyrimidones / Hydropyrimidines
show 18 more
Substituents
Alcohol / Alkyl phosphate / Aromatic heteromonocyclic compound / Azacycle / Beta-hydroxy acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Glucuronic acid or derivatives / Glycosyl compound
show 34 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
UDP-sugar (CHEBI:17200)
Affected organisms
Not Available

Chemical Identifiers

UNII
04SZC4MEFQ
CAS number
2616-64-0
InChI Key
HDYANYHVCAPMJV-LXQIFKJMSA-N
InChI
InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1
IUPAC Name
(2S,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
SMILES
O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O

References

General References
Not Available
Human Metabolome Database
HMDB0000935
KEGG Compound
C00167
PubChem Compound
17473
PubChem Substance
46504863
ChemSpider
16522
BindingDB
50209665
ChEBI
17200
ChEMBL
CHEMBL228057
ZINC
ZINC000008215691
PDBe Ligand
UGA
Wikipedia
Uridine_diphosphate_glucuronic_acid
PDB Entries
1dlj / 1kws / 1z7e / 2qg4 / 2y0c / 2y0d / 2y0e / 2z86 / 3gg2 / 3pjg …
show 8 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility18.1 mg/mLALOGPS
logP-1.2ALOGPS
logP-4.7Chemaxon
logS-1.5ALOGPS
pKa (Strongest Acidic)1.72Chemaxon
pKa (Strongest Basic)-3.7Chemaxon
Physiological Charge-3Chemaxon
Hydrogen Acceptor Count15Chemaxon
Hydrogen Donor Count9Chemaxon
Polar Surface Area308.61 Å2Chemaxon
Rotatable Bond Count9Chemaxon
Refractivity106.32 m3·mol-1Chemaxon
Polarizability45.33 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.9675
Blood Brain Barrier+0.522
Caco-2 permeable-0.8251
P-glycoprotein substrateNon-substrate0.7638
P-glycoprotein inhibitor INon-inhibitor0.8023
P-glycoprotein inhibitor IINon-inhibitor0.9441
Renal organic cation transporterNon-inhibitor0.9396
CYP450 2C9 substrateNon-substrate0.6646
CYP450 2D6 substrateNon-substrate0.8589
CYP450 3A4 substrateNon-substrate0.5312
CYP450 1A2 substrateNon-inhibitor0.867
CYP450 2C9 inhibitorNon-inhibitor0.8764
CYP450 2D6 inhibitorNon-inhibitor0.8742
CYP450 2C19 inhibitorNon-inhibitor0.8316
CYP450 3A4 inhibitorNon-inhibitor0.7204
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8237
Ames testNon AMES toxic0.8575
CarcinogenicityNon-carcinogens0.9131
BiodegradationNot ready biodegradable0.5835
Rat acute toxicity2.3361 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9732
hERG inhibition (predictor II)Non-inhibitor0.6161
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0w29-3322930000-0ce18416678ea80bec67
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0gx0-0000390000-c05a292a06352df88e51
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-0000190000-57922756e57a6d5f8d25
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0ik9-0211950000-67e4e0740d4bbd5805ea
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00n0-2001390000-4f2d9df8d00701a731d5
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-2933810000-30ef4bf5d4d99f61b39b
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a59-7615960000-04f5eab22664749ad4b0
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-233.6016812
predicted
DarkChem Lite v0.1.0
[M-H]-238.3393812
predicted
DarkChem Lite v0.1.0
[M-H]-236.1036812
predicted
DarkChem Lite v0.1.0
[M-H]-214.6184
predicted
DeepCCS 1.0 (2019)
[M+H]+235.8395812
predicted
DarkChem Lite v0.1.0
[M+H]+242.3083812
predicted
DarkChem Lite v0.1.0
[M+H]+239.3626812
predicted
DarkChem Lite v0.1.0
[M+H]+216.3421
predicted
DeepCCS 1.0 (2019)
[M+Na]+234.6653812
predicted
DarkChem Lite v0.1.0
[M+Na]+239.3127812
predicted
DarkChem Lite v0.1.0
[M+Na]+235.5726812
predicted
DarkChem Lite v0.1.0
[M+Na]+222.67105
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. UDP-glucose 4-epimerase
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
General Function
Udp-n-acetylglucosamine 4-epimerase activity
Specific Function
Catalyzes two distinct but analogous reactions: the reversible epimerization of UDP-glucose to UDP-galactose and the reversible epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine...
Gene Name
GALE
Uniprot ID
Q14376
Uniprot Name
UDP-glucose 4-epimerase
Molecular Weight
38281.435 Da
References
  1. Bhatia C, Oerum S, Bray J, Kavanagh KL, Shafqat N, Yue W, Oppermann U: Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships. Chem Biol Interact. 2015 Jun 5;234:114-25. doi: 10.1016/j.cbi.2014.12.013. Epub 2014 Dec 16. [Article]
Details2. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Protein phosphatase activator activity
Specific Function
Glycosaminoglycans biosynthesis. Involved in forming the linkage tetrasaccharide present in heparan sulfate and chondroitin sulfate. Transfers a glucuronic acid moiety from the uridine diphosphate-...
Gene Name
B3GAT3
Uniprot ID
O94766
Uniprot Name
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3
Molecular Weight
37121.52 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Details3. UDP-glucose 6-dehydrogenase
Kind
Protein
Organism
Streptococcus pyogenes
Pharmacological action
Unknown
General Function
Udp-glucose 6-dehydrogenase activity
Specific Function
Catalyzes the formation of UDP-glucuronic acid which is required for capsular hyaluronic acid synthesis.
Gene Name
hasB
Uniprot ID
P0C0F4
Uniprot Name
UDP-glucose 6-dehydrogenase
Molecular Weight
45482.795 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52